Craig M Zaidman1, Jim S Wu2, Kush Kapur3, Amy Pasternak4, Lavanya Madabusi3, Sung Yim5, Adam Pacheck5, Heather Szelag1, Tim Harrington1, Basil T Darras3, Seward B Rutkove5. 1. Department of Neurology, Washington University in St Louis, St Louis, MO. 2. Department of Radiology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA. 3. Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, MA. 4. Department of Physical Therapy Services and Occupational Therapy Services, Boston Children's Hospital, Boston, MA. 5. Department of Neurology, Beth Israel Deaconess Medical Center, Boston, MA.
Abstract
OBJECTIVE: We assessed changes in quantitative muscle ultrasound data in boys with Duchenne muscular dystrophy (DMD) and healthy controls to determine whether ultrasound can serve as a biomarker of disease progression. Two approaches were used: gray scale level (GSL), measured from the ultrasound image, and quantitative backscatter analysis (QBA), measured directly from the received echoes. METHODS: GSL and QBA were obtained from 6 unilateral arm/leg muscles in 36 boys with DMD and 28 healthy boys (age = 2-14 years) for up to 2 years. We used a linear mixed effects model with random intercept and slope terms to compare trajectories of GSL, QBA, and functional assessments. We analyzed separately a subset of boys who initiated corticosteroids. RESULTS: Compared to healthy boys, increasing GSL in DMD boys >7.0 years old was first identified at 6 months (eg, anterior forearm slope difference of 1.16 arbitrary units/mo, p = 0.004, 95% confidence interval [CI] = 0.38-1.94); in boys ≤ 7 years old, differences in GSL first appeared at 12 months (0.82 arbitrary units/mo, p = 0.04, 95% CI = 0.075-1.565, in rectus femoris). QBA performed similarly to GSL (eg, DMD boys > 7 years old: 0.41dB/mo, p = 0.01, 95% CI = 0.096-0.72, in anterior forearm at 6 months). Ultrasound identified differences earlier than functional measures including 6-minute walk and supine-to-stand tests. However, neither QBA nor GSL showed an effect of corticosteroid initiation. INTERPRETATION: QBA performs similarly to GSL, and both appear more sensitive than functional assessments for detecting muscle deterioration in DMD. Additional studies will be required to determine whether quantitative muscle ultrasound can detect therapeutic efficacy. Ann Neurol 2017;81:633-640.
OBJECTIVE: We assessed changes in quantitative muscle ultrasound data in boys with Duchenne muscular dystrophy (DMD) and healthy controls to determine whether ultrasound can serve as a biomarker of disease progression. Two approaches were used: gray scale level (GSL), measured from the ultrasound image, and quantitative backscatter analysis (QBA), measured directly from the received echoes. METHODS:GSL and QBA were obtained from 6 unilateral arm/leg muscles in 36 boys with DMD and 28 healthy boys (age = 2-14 years) for up to 2 years. We used a linear mixed effects model with random intercept and slope terms to compare trajectories of GSL, QBA, and functional assessments. We analyzed separately a subset of boys who initiated corticosteroids. RESULTS: Compared to healthy boys, increasing GSL in DMDboys >7.0 years old was first identified at 6 months (eg, anterior forearm slope difference of 1.16 arbitrary units/mo, p = 0.004, 95% confidence interval [CI] = 0.38-1.94); in boys ≤ 7 years old, differences in GSL first appeared at 12 months (0.82 arbitrary units/mo, p = 0.04, 95% CI = 0.075-1.565, in rectus femoris). QBA performed similarly to GSL (eg, DMDboys > 7 years old: 0.41dB/mo, p = 0.01, 95% CI = 0.096-0.72, in anterior forearm at 6 months). Ultrasound identified differences earlier than functional measures including 6-minute walk and supine-to-stand tests. However, neither QBA nor GSL showed an effect of corticosteroid initiation. INTERPRETATION:QBA performs similarly to GSL, and both appear more sensitive than functional assessments for detecting muscle deterioration in DMD. Additional studies will be required to determine whether quantitative muscle ultrasound can detect therapeutic efficacy. Ann Neurol 2017;81:633-640.
Authors: Sigrid Pillen; Ramon O Tak; Machiel J Zwarts; Martin M Y Lammens; Kiek N Verrijp; Ilse M P Arts; Jeroen A van der Laak; Peter M Hoogerbrugge; Baziel G M van Engelen; Aad Verrips Journal: Ultrasound Med Biol Date: 2008-12-10 Impact factor: 2.998
Authors: E Mazzone; G Vasco; M P Sormani; Y Torrente; A Berardinelli; S Messina; A D'Amico; L Doglio; L Politano; F Cavallaro; S Frosini; L Bello; S Bonfiglio; E Zucchini; R De Sanctis; M Scutifero; F Bianco; F Rossi; M C Motta; A Sacco; M A Donati; T Mongini; A Pini; R Battini; E Pegoraro; M Pane; S Gasperini; S Previtali; S Napolitano; D Martinelli; C Bruno; G Vita; G Comi; E Bertini; E Mercuri Journal: Neurology Date: 2011-07-06 Impact factor: 9.910
Authors: Craig M Zaidman; Anne M Connolly; Elizabeth C Malkus; Julaine M Florence; Alan Pestronk Journal: Neuromuscul Disord Date: 2010-12 Impact factor: 4.296
Authors: Merel Jansen; Nens van Alfen; Maria W G Nijhuis van der Sanden; Johannes P van Dijk; Sigrid Pillen; Imelda J M de Groot Journal: Neuromuscul Disord Date: 2011-11-30 Impact factor: 4.296
Authors: Jill E Mayhew; Julaine M Florence; Thomas P Mayhew; Erik K Henricson; Robert T Leshner; Robert J McCarter; Diana M Escolar Journal: Muscle Nerve Date: 2007-01 Impact factor: 3.217
Authors: Rebecca J Willcocks; William D Rooney; William T Triplett; Sean C Forbes; Donovan J Lott; Claudia R Senesac; Michael J Daniels; Dah-Jyuu Wang; Ann T Harrington; Gihan I Tennekoon; Barry S Russman; Erika L Finanger; Barry J Byrne; Richard S Finkel; Glenn A Walter; H Lee Sweeney; Krista Vandenborne Journal: Ann Neurol Date: 2016-02-19 Impact factor: 10.422
Authors: Craig M McDonald; Erik K Henricson; Jay J Han; R Ted Abresch; Alina Nicorici; Gary L Elfring; Leone Atkinson; Allen Reha; Samit Hirawat; Langdon L Miller Journal: Muscle Nerve Date: 2010-04 Impact factor: 3.217
Authors: Anne M Connolly; Julaine M Florence; Craig M Zaidman; Paul T Golumbek; Jerry R Mendell; Kevin M Flanigan; Peter I Karachunski; John W Day; Craig M McDonald; Basil T Darras; Peter B Kang; Catherine A Siener; Rebecca K Gadeken; Pallavi Anand; Jeanine R Schierbecker; Elizabeth C Malkus; Linda P Lowes; Lindsay N Alfano; Linda Johnson; Alina Nicorici; Jason M Kelecic; Janet Quigley; Amy E Pasternak; J Philip Miller Journal: Muscle Nerve Date: 2016-05-10 Impact factor: 3.217
Authors: Seward B Rutkove; Kush Kapur; Craig M Zaidman; Jim S Wu; Amy Pasternak; Lavanya Madabusi; Sung Yim; Adam Pacheck; Heather Szelag; Tim Harrington; Basil T Darras Journal: Ann Neurol Date: 2017-05-04 Impact factor: 10.422
Authors: Bhaskar Roy; Basil T Darras; Craig M Zaidman; Jim S Wu; Kush Kapur; Seward B Rutkove Journal: Clin Neurophysiol Date: 2019-02-12 Impact factor: 3.708
Authors: Marianela Schiava; Rachel Amos; Henriette VanRuiten; Michael P McDermott; Williams B Martens; Stephanie Gregory; Anna Mayhew; Elaine McColl; Rabi Tawil; Tracey Willis; Kate Bushby; Robert C Griggs; Michela Guglieri Journal: Neurology Date: 2021-12-02 Impact factor: 9.910
Authors: Hala Abdulhady; Hossam M Sakr; Nermine S Elsayed; Tamer A El-Sobky; Nagia Fahmy; Amr M Saadawy; Heba Elsedfy Journal: Acta Myol Date: 2022-03-31
Authors: Karlien Mul; Chad Heatwole; Katy Eichinger; Nuran Dilek; William B Martens; Baziel G M Van Engelen; Rabi Tawil; Jeffrey M Statland Journal: Muscle Nerve Date: 2018-04-17 Impact factor: 3.217
Authors: Kush Kapur; Benjamin Sanchez; Adam Pacheck; Basil Darras; Seward B Rutkove; Rajesh Selukar Journal: IEEE Trans Biomed Eng Date: 2018-11-01 Impact factor: 4.538